Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Int Forum Allergy Rhinol. 2016 Feb 8;6(6):590–596. doi: 10.1002/alr.21721

Table 4. Prevalence of patient-reported medication use (in the past 90 days) for sinusitis at baseline and follow-up study evaluations (n=75).

Baseline Last Available Follow-up (≥6 months)
Medication regimen: n (%) n (%) p-value
Topical nasal steroid sprays 56 (75%) 45 (60%) 0.035
Topical nasal steroid drops/irrigations 22 (29%) 28 (37%) 0.286
Decongestants 35 (47%) 28 (37%) 0.230
Oral antibiotics 41 (55%) 20 (27%) <0.001
Oral/systemic corticosteroid 38 (51%) 15 (20%) <0.001
Antihistamines 39 (52%) 27 (36%) 0.008
Leukotriene modifiers 19 (25%) 18 (24%) >0.999
Saline irrigations rinse 63 (84%) 57 (76%) 0.210

p-value represents significance using McNemar's chi-square test statistics